Epsilon M&A Deal Report - Quantum Specials
Transaction Multiples for the Valuation of Private Companies
Private Group led by LloydsTSB Development Capital / Quantum Specials
No EMAT :
19711
Announced Date :
03/02/2009
Type :
MBO (Management Buy Out) ,Exit
Deal Value :
Yes
Acquirer :
Private Group led by LloydsTSB Development Capital
Target :
Quantum Specials
Country :
England
Sector of activity :
- Pharmaceuticals & Cosmetics R&W > Retail and Wholesale ('R&W') > Drugs Retailers
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Quantum Specials Ltd manufactures and supplies pharmaceutical products and medicines in the United Kingdom. > Products include: oral solutions and suspensions; ointments, creams and pastes; unit...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|||||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Drugs Retailers » = 53
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 130
| Date | Acquirer | Target | Country | Multiples | See details |
| 21/12/2008 | Unknown | Pinewood Laboratories | Ireland | * | 19706 |
| 02/12/2008 | Private Group led by Magnum Industrial Partners | Farma-APS Produtos Farmaceuticos | Portugal | * | 19705 |
Source: Epsilon Research / EMAT
